Clark Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.89K Buy
+112
New +$5.18K ﹤0.01% 407
2026
Q2
– Sell
-73
Closed -$4.58K – 582
2026
Q1
$4.58K Sell
73
-12
-14% -$960 ﹤0.01% 348
2025
Q4
$8.1K Hold
85
– – ﹤0.01% 268
2025
Q3
$8.1K Sell
85
-42
-33% -$4.35K ﹤0.01% 268
2025
Q2
$13.6K Buy
127
+18
+17% +$1.82K 0.01% 187
2025
Q1
$11K Hold
109
– – 0.01% 195
2024
Q4
$9.7K Buy
+109
New +$9.6K 0.01% 176

Other funds holding BSX

Clark Wealth Partners's BSX Position: Q3 2026 in Review

Clark Wealth Partners opened a new position in Boston Scientific (BSX) in Q3 2026: 112 shares worth $4.89K. The stake represents ﹤0.01% of the portfolio and ranks #407 among its holdings. This is a return to the name: Clark Wealth Partners previously reported a position in BSX as recently as Q1 2026.

Clark Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.6K in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Clark Wealth Partners held 112 shares of Boston Scientific worth $4.89K as of Q3 2026.
  • Boston Scientific was a new Clark Wealth Partners position in Q3 2026.
  • Boston Scientific made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #407 holding.
  • Clark Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's Boston Scientific position peaked at $13.6K in Q2 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.